JavaScript seems to be disabled in your browser. You must have JavaScript enabled in your browser to utilize the functionality of this website.
Description: Erteberel (also known as LY500307) is a novel, potent and selective estrogen receptor beta (ERbeta) inhibitor with Ki and EC50 of 1.54 nM and 3.61 nM, respectively. It has anti-tumor activities and was developed for the treatment of benign prostatic hyperplasia. LY500307 was well tolerated in BPH patients with LUTS at doses up to 25?mg once daily for 24 weeks. The study was terminated early because of inadequate efficacy.
References: Proc Natl Acad Sci U S A. 2018 Apr 17; 115(16):E3673-E3681.; Sci Rep. 2016 Apr 29; 6:24185.
Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.
All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.
Request Data Sheet
Request product datasheet
Request safety datasheet
Compare
Add to wishlist
Get an offer
Request delivery time
Ask a technical question
Submit a bulk request
sales@hoelzel.de
« Back
Subscribe, get 15% off every fifth order and have your items delivered on time!
Forgot Your Password?
Not yet registered? Create account here!